Citi Pharma earns Rs833m in FY24

News Image

MG News | October 02, 2024 at 09:22 AM GMT+05:00

0:00

October 02, 2024 (MLN): Citi Pharma Ltd. (PSX: CPHL) earned a net profit of Rs833.46 million in the financial year 2024, translating into earnings per share (EPS) of Rs3.65.

That is up 26.7% from the profit of Rs657.98m [EPS: Rs2.88] recorded in FY23. The increase was in part led by higher margins and other income.

Along with the results, the company announced a final cash dividend of Rs3.25 per share, i.e. 32.5%.

Going by the results, the company's revenue remained largely stable at Rs12.41bn while the cost of sales inched down by 0.6%.

The gross profit improved by 5.3% to Rs1.59bn in FY24. Gross margins rose to 12.8% as compared to 12.2% in SPLY.

During the period under review, other income jumped 67.6% to stand at Rs489.67m in FY24 as compared to Rs292.22m last year.

On the expense side, the company's administrative expenses rose 8.4% from last year to Rs204.14m, selling and distribution expenses rose 16.7% to Rs176.41m, while other operating expenses fell 1.7% to Rs114.2m.

The company’s finance cost decreased by 22.4% and stood at Rs299.91m as compared to Rs386.23m in FY23.

On the tax front, the company paid a higher tax worth Rs447.74m against the Rs299.27m paid in the corresponding period of last year, depicting an increase of 49.6%.

This translates to an effective tax rate of 34.9% as compared to 31.3% in FY23.

Unconsolidated (un-audited) Financial Results for year ended June 30, 2024 (Rupees in '000)
  Jun 24 Jun 23 % Change
Sales 12,409,239 12,396,983 0.10%
Cost of sales (10,823,044) (10,889,870) -0.61%
Gross Profit/ (loss) 1,586,195 1,507,113 5.25%
Administrative Expenses (204,141) (188,414) 8.35%
Selling And Distribution Expenses (176,413) (151,222) 16.66%
Other Income 489,667 292,221 67.57%
Other Operating Expenses (114,201) (116,211) -1.73%
Finance Cost (299,906) (386,234) -22.35%
Profit/ (loss) before taxation 1,281,202 957,254 33.84%
Taxation (447,738) (299,270) 49.61%
Net profit/ (loss) for the period 833,464 657,984 26.67%
Basic earnings/ (loss) per share 3.65 2.88 -

Amount in thousand except for EPS

Copyright Mettis Link News

Related News

Name Price/Vol %Chg/NChg
KSE100 163,304.13
424.61M
-0.78%
-1286.28
ALLSHR 99,380.97
1,038.42M
-0.94%
-946.44
KSE30 49,842.51
138.16M
-0.73%
-367.30
KMI30 238,104.17
78.33M
-0.14%
-327.97
KMIALLSHR 65,590.95
485.77M
-0.66%
-435.42
BKTi 45,705.29
72.87M
-2.08%
-972.73
OGTi 32,671.23
13.00M
-0.23%
-74.93
Symbol Bid/Ask High/Low
Name Last High/Low Chg/%Chg
BITCOIN FUTURES 110,990.00 112,355.00
109,820.00
570.00
0.52%
BRENT CRUDE 65.69 66.78
65.41
-0.30
-0.45%
RICHARDS BAY COAL MONTHLY 80.50 0.00
0.00
-1.05
-1.29%
ROTTERDAM COAL MONTHLY 92.60 0.00
0.00
0.10
0.11%
USD RBD PALM OLEIN 1,082.50 1,082.50
1,082.50
0.00
0.00%
CRUDE OIL - WTI 61.44 62.59
61.21
-0.35
-0.57%
SUGAR #11 WORLD 14.97 15.34
14.93
-0.32
-2.09%

Chart of the Day


Latest News
October 24, 2025 at 05:12 PM GMT+05:00

AGP limited profit soars 80% in 9MFY25


October 24, 2025 at 05:06 PM GMT+05:00

PSX Closing Bell: Fading Out on Friday


October 24, 2025 at 04:38 PM GMT+05:00

Searle company triples Q1 profit to Rs853.5m


October 24, 2025 at 04:30 PM GMT+05:00

Lalpir Power's 9MFY25 performance reverses to loss



Top 5 things to watch in this week

Pakistan Stock Movers
Name Last Chg/%Chg
Name Last Chg/%Chg